Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent ...
Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding ...
Glucose-monitor vendor DexCom announced a pairing Tuesday with the seller of Oura smart rings. Apps available in the first half of next year will combine DexCom blood-glucose readings with the ...
Dexcom on Tuesday announced an artificial intelligence feature for its Stelo continuous glucose monitor that gives users a personalized look into how meals, sleep and activity impact their glucose ...
Dexcom has become the first company to launch a generative AI-powered continuous glucose monitor. The San Diego healthcare company announced the launch of its proprietary product after leveraging ...
Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens new ... between them related to continuous glucose monitoring devices. The agreement will dismiss all ...
Bengaluru: Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement ...
This is one of the biggest and most exciting developments in glucose monitoring for years. Whether you use the Dexcom Stelo or opt for the more advanced Dexcom G7, there’s never been a better ...
Dexcom revealed on Tuesday an artificial intelligence function for their Stelo continuous glucose monitor that allows users to see how their blood sugar levels are affected by food, sleep, and ...
During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...